seed
Stage
2026
Founded
3
Investors
About
BrainZell specializes in generating high-throughput brain organoids derived from induced pluripotent stem cells (iPSCs) to mimic human neural biology, enabling drug discovery and development for neurological diseases.
Explore BrainZell's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.